LUCID GROUP, INC. INVESTORS WITH LOSSES HAVE UNTIL JULY 28,
Bernstein Liebhard LLP reminds investors of Lucid Group, Inc. (NASDAQ: LCID) that they have until July 28, 2026, to join a securities fraud class-action lawsuit. The lawsuit alleges that the Company made materially false and misleading statements between February 25, 2026, and April 13, 2026, leading to artificially inflated stock prices and investor losses. Investors who suffered losses are encouraged to contact Bernstein Liebhard LLP to learn more about the class action.
FS KKR CAPITAL CORP. INVESTORS WITH LOSSES HAVE UNTIL JULY
Bernstein Liebhard LLP reminds investors of FS KKR Capital Corp. (NYSE: FSK) that they have until July 6, 2026, to join a securities fraud class action lawsuit. The lawsuit alleges that FS KKR Capital made false and misleading statements, leading to artificially inflated stock prices and investor losses. Investors who purchased shares between May 8, 2024, and February 25, 2026, and suffered losses are encouraged to contact the firm.
Exelon Corp. stock (US30161N1019): ex-dividend date in focus ahead of June 4
Exelon Corp. (US30161N1019) shares are gaining investor attention ahead of their ex-dividend date on June 4, 2026, and following the release of their first-quarter earnings in early May. The utility group, listed on Nasdaq, last closed at $45.64, with an annualized dividend of $1.68 per share, yielding approximately 3.68%. The article highlights Exelon's regulated utility business model, emphasizing stable cash generation and earnings visibility for U.S. investors.
ANCA Vasculitis Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | CSL, Amgen, NS Pharma, Amgen, GlaxoSmithKline, AstraZeneca, Chemocentry, Staidson (Beijing) Biopharma
The ANCA Vasculitis market is projected to grow from approximately USD 1.8 billion in 2025 to nearly USD 3.8 billion by 2036, driven by increased prevalence, advanced diagnostics, and new targeted therapies. Key players like CSL, Amgen, and GlaxoSmithKline are developing and expanding treatments such as avacopan and mepolizumab for this autoimmune disease. Despite growth, market barriers include the rare disease population, high treatment costs, and diagnostic delays.
Lumber Now Available on Trimble Marketplace for Vista & Spectrum Users
Lumber, an AI-native construction workforce management platform, is now available on Trimble Marketplace for Trimble Vista and Spectrum users. This integration allows contractors to streamline labor data flow, improve payroll accuracy, and enhance job costing and workforce reporting by connecting Lumber's workforce management tools with Trimble's financial management solutions. The move aims to provide contractors with expanded options for modern workforce, payroll, and compliance technology to address challenges like labor shortages and compliance complexity.
Stryker launches TPX HD power tool for orthopaedic procedures
Stryker has introduced TPX HD, a new small bone power tool designed for various orthopedic procedures, including total joint revisions and minimally invasive surgeries. The device offers enhanced torque and speed compared to previous models, with features for improved visibility and heat management. Despite a recent cyber incident impacting Q1 2026 earnings, Stryker reaffirmed its 2026 guidance and increased its quarterly dividend.
Jianzhi Education prices $5M registered direct offering
Jianzhi Education Technology Group Company Limited has announced a registered direct offering of 5 million American Depositary Shares and accompanying Series A warrants, aiming to raise approximately $5 million. The proceeds will be used for working capital and general corporate purposes, including business operations, content development, and marketing. This capital raise comes as the company faces a significant revenue decline and operating losses, although it maintains a healthy cash-to-debt ratio and current ratio.
Chipotle Mexican Grill stock hits 52-week low at 29.68 USD
Chipotle Mexican Grill (CMG) stock has hit a 52-week low of $29.62, representing a 39.92% decrease over the past year from its high of $58.42. Despite 26 analysts revising earnings downwards, InvestingPro's Fair Value analysis suggests the stock might be undervalued. This downturn follows Q1 2026 earnings where the company met analyst forecasts with $0.24 EPS and slightly surpassed revenue expectations at $3.09 billion, driven by digital sales.
Verisk Updates its Hurricane Model For USA
Verisk (Nasdaq: VRSK) has released a major update to its U.S. Tropical Cyclone model, designed to provide comprehensive advancements in quantifying hurricane risk for insurance, reinsurance, and capital markets. Delivered on its cloud-native Synergy Studio platform, the updated model incorporates a near-present climate view, enhanced hazard and vulnerability modeling, and a re-evaluation of loss drivers, including storm surge and inland flooding. These advancements aim to offer a more accurate, transparent, and defensible view of risk, reflecting modern construction practices, climate conditions, and tropical cyclone behavior.
Applied Materials: The AI Stock That Wins No Matter Which Chip Wins
Applied Materials (AMAT) is presented as a strong AI investment due to its essential role in manufacturing nearly all critical AI chip components. The article highlights three key pillars for its growth: increasing complexity in logic chips, the rise of high-bandwidth memory (HBM), and the rapid expansion of advanced packaging technologies. Applied Materials' broad involvement across the semiconductor manufacturing process positions it to benefit regardless of which specific chip architecture ultimately dominates the AI landscape, leading to increased investor visibility and a re-evaluation of its valuation.


